aTyr Pharma Inc. (NASDAQ: ATYR) announced that the last patient completed their final visit in the company's Phase 3 EFZO-FIT ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE